Health & Fitness
Tue, August 24, 2010Mon, August 23, 2010Fri, August 20, 2010Thu, August 19, 2010Wed, August 18, 2010Tue, August 17, 2010Mon, August 16, 2010Fri, August 13, 2010Thu, August 12, 2010Wed, August 11, 2010Tue, August 10, 2010Mon, August 9, 2010Fri, August 6, 2010Thu, August 5, 2010Wed, August 4, 2010Tue, August 3, 2010Mon, August 2, 2010Fri, July 30, 2010Thu, July 29, 2010Genoptix Announces Participation at 2010 Southern California Investor Conference
Published in Health and Fitness on Wednesday, August 11th 2010 at 4:10 GMT by Market Wire
Genoptix Announces Participation at 2010 Southern California Investor Conference -- CARLSBAD, Calif., Aug. 11 /PRNewswire-FirstCall/ --
Genoptix Announces Participation at 2010 Southern California Investor Conference
CARLSBAD, Calif., Aug. 11 /PRNewswire-FirstCall/ -- Genoptix, Inc. (Nasdaq: GXDX), a specialized laboratory services provider, today announced the Company's participation at the Southern California Investor Conference to be held August 17, 2010 at The Island Hotel, Newport Beach, CA.
Marcy Graham, Executive Director of Investor Relations will present on Tuesday, August 17, beginning at 11:30 a.m. PDT, when she will provide an overview of the Company's specialized diagnostic laboratory services business.
The presentation is expected to last approximately 30 minutes and will be web cast live through the "Investors" section of the Genoptix website at [ www.genoptix.com ]. Those who would like to listen to the presentation should go to this site at least 15 minutes prior to the event to register, download and install any necessary software. An audio replay will be available for 30 days following the initial presentation web cast.
About Genoptix, Inc.
Genoptix is a leading specialized laboratory service provider focused on delivering personalized and comprehensive diagnostic services to its physician customers, community-based hematologists and oncologists. On the forefront of personalized diagnostic services, Genoptix's highly trained group of hematopathologists utilize sophisticated technology to provide integrated testing and actionable diagnostic reports. Its diagnostic services are designed to optimize the care of patients suffering from hematomalignancies, or cancers of the blood and bone marrow, including leukemia and lymphoma, and other forms of cancer.Founded in 1999, Genoptix is a member of the Nasdaq Global Select Market, the S&P SmallCap 600 Index and the Russell 2000 Index and is headquartered in Carlsbad, California. For more information, please visit [ www.genoptix.com ].
Forward-Looking Statements
This press release contains forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in the forward-looking statements. Genoptix disclaims, however, any intent or obligation to update these forward-looking statements.
SOURCE Genoptix, Inc.
[ Back to top ]RELATED LINKS
[ http://www.genoptix.com ]
Other News Releases in Biotechnology
[ The Cloudburst Group Appoints Ajay Vatave, MD, MPH, as Director, Center for Public Health ]
[ InspireMD Announce That MGuard(TM) is Now Available With a New Delivery System Also in South America ]
[ Chip Supply Hosts Visit by U.S. Senator George LeMieux ]
Other News Releases in Trade Show News
[ InspireMD Announce That MGuard? Is Now Available With a New Delivery System Also in South America ]
[ Is Your Copier a Security Threat? ]
[ WSA Donates Nearly $70K to TWO TEN Foundation ]
Journalists and Bloggers
Visit [ PR Newswire for Journalists ] for releases, photos, ProfNet experts, and customized feeds just for Media.
View and download archived video content distributed by MultiVu on [ The Digital Center ].
